Health-care companies ticked down as traders hedged their bets on the outlook for growth in the sector.
Hims & Hers Health shares surged after the online pharmacy added GLP-1 injections to its weight-loss offering, capitalizing on the popularity of Ozempic and other obesity drugs.
Shares of Novo Nordisk ticked up. The U.S. Food and Drug Administration gave a green light to Elon Musk's Neuralink to implant its brain chip in a second person, signing off on the company's proposed fixes for a problem that occurred in the first test participant.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
05-20-24 1726ET
